Novel targets for antithrombotic drug discovery

Blood Cells, Molecules, and Diseases

Volumn 36, Issue 2, 2006, Pages 228-231

  Nanda, Nisha ^a   Phillips, David R ^a  

^a Portola Pharmaceuticals Inc   (United States)

Author keywords

CD84; Co receptors; PEAR1; Platelet aggregation; SLAM

Indexed keywords

ANTICOAGULANT AGENT; CD150 ANTIGEN; CELL ADHESION MOLECULE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE RECEPTOR; PROTEIN PEAR1; UNCLASSIFIED DRUG;

ARTICLE; GENOMICS; HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOSIS;

ANIMALS; ANTIGENS, CD; DRUG DELIVERY SYSTEMS; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 33645322162     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2005.12.026     Document Type: Article

References (12)

1. N. Nanda, P. Andre, and M. Bao Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling Blood 106 2005 3028 3034
2. N. Nanda, M. Bao, and H. Lin Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation J. Biol. Chem. 280 2005 24680 24689
3. C.S. Fox, L. Sullivan, R.B. D'Agostino Sr., and P.W. Wilson The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study Diabetes Care 27 2004 704 708
4. B. Chan, A. Lanyi, and H.K. Song SAP couples Fyn to SLAM immune receptors Nat. Cell Biol. 5 2003 155 160
5. S.G. Tangye, B.C. van de Weerdt, D.T. Avery, and P.D. Hodgkin CD84 is up-regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2 Eur. J. Immunol. 32 2002 1640 1649
6. M. Martin, X. Romero, and M.A. de la Fuente CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1 J. Immunol. 167 2001 3668 3676
7. S.G. Tangye, K.E. Nichols, N.J. Hare, and B.C. van de Weerdt Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation J. Immunol. 171 2003 2485 2495
8. D.R. Phillips, K.S. Prasad, J. Manganello, M. Bao, and L. Nannizzi-Alaimo Integrin tyrosine phosphorylation in platelet signaling Curr. Opin. Cell Biol. 13 2001 546 554
9. J. Schlessinger Ligand-induced, receptor-mediated dimerization and activation of EGF receptor Cell 110 2002 669 672
10. E. Migliaccio, S. Mele, and A.E. Salcini Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway EMBO J. 16 1997 706 716
11. K.J. Cowan, D.A. Law, and D.R. Phillips Identification of shc as the primary protein binding to the tyrosine-phosphorylated beta 3 subunit of alpha IIbbeta 3 during outside-in integrin platelet signaling J. Biol. Chem. 275 2000 36423 36429
12. D.A. Law, L. Nannizzi-Alaimo, and D.R. Phillips Outside-in integrin signal transduction. Alpha IIb beta 3-(GP IIb IIIa) tyrosine phosphorylation induced by platelet aggregation J. Biol. Chem. 271 1996 10811 10815